SAB Biotherapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 377.83K, Increased -71.43%. In the fiscal year ending Dec 31, 2024, SAB Biotherapeutics had annual revenue of 1.32M with -40.96% growth.